Health Care [ 4/12 ] | Biotechnology [ 17/74 ]
NASDAQ | Common Stock
Mainz BiomedN. V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States.
The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test.
It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer.
It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product.
The company was founded in 2008 and is based in Mainz, Germany.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 9, 24 | -0.24 Increased by +46.67% | -0.32 Increased by +25.00% |
| Mar 6, 24 | -0.24 Increased by +47.83% | -0.32 Increased by +24.22% |
| Nov 16, 23 | -0.39 Increased by +9.30% | -0.47 Increased by +17.02% |
| Aug 15, 23 | -0.56 Decreased by -21.74% | -0.42 Decreased by -33.33% |
| Apr 27, 23 | -0.45 Increased by +46.43% | -0.46 Increased by +2.17% |
| Mar 8, 23 | -0.46 Decreased by -1.43 K% | -0.46 |
| Nov 2, 22 | -0.43 Decreased by -2.05 K% | -0.43 |
| Sep 7, 22 | -0.46 Decreased by -283.97% | -0.46 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 214.76 K Decreased by -14.13% | -5.18 M Increased by +21.87% | Decreased by -2.41 K% Increased by +9.01% |
| Dec 31, 23 | 214.76 K Increased by +48.79% | -5.18 M Decreased by -77.36% | Decreased by -2.41 K% Decreased by -19.20% |
| Sep 30, 23 | 181.67 K Increased by +87.69% | -6.30 M Decreased by -12.57% | Decreased by -3.47 K% Increased by +40.02% |
| Jun 30, 23 | 248.94 K Increased by +78.79% | -8.25 M Decreased by -18.92% | Decreased by -3.31 K% Increased by +33.48% |
| Mar 31, 23 | 250.10 K Increased by +56.28% | -6.63 M Increased by +41.95% | Decreased by -2.65 K% Increased by +62.85% |
| Dec 31, 22 | 144.34 K Increased by 0.00% | -2.92 M Increased by +2.86% | Decreased by -2.02 K% Increased by +2.86% |
| Sep 30, 22 | 96.79 K Decreased by -32.94% | -5.60 M Decreased by -91.49% | Decreased by -5.78 K% Decreased by -185.55% |
| Jun 30, 22 | 139.24 K Decreased by -66.63% | -6.94 M Decreased by -2.78 K% | Decreased by -4.98 K% Decreased by -8.54 K% |